Sylvie Hermouet, and Mathias Vilaine. 2011. “The JAK2 46/1 Haplotype: A Marker of Inappropriate Myelomonocytic Response to Cytokine Stimulation, Leading to Increased Risk of Inflammation, Myeloid Neoplasm, and Impaired Defense Against Infection?”. Haematologica 96 (11). Pavia, Italy, 1575-79. https://doi.org/10.3324/haematol.2011.055392.